An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

Nonparametric Estimation from Incomplete Observations

Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239

Nonparametric Estimation from Incomplete Observations

Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

Paik, S., Shak, S., Tang, G., Kim, C., Baker, J. B., Cronin, M. T., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,321

affy—analysis of Affymetrix GeneChip data at the probe level

Gautier, L., Cope, L., Bolstad, B. M., & Irizarry, R. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg405 · Cited by 5,221

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

Wang, Y., Klijn, J. G. M., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M. A. M., Gelder, M. E. M., Yu, J. X., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,831

Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

Paik, S., Tang, G., Shak, S., Kim, C., Baker, J. B., Kim, W., Cronin, M. T., Baehner, F. L., Watson, D., Bryant, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7985 · Cited by 2,597

American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer

Harris, L. N., Fritsche, H. A., Mennel, R. G., Norton, L., Ravdin, P. M., Taube, S. E., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,234

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

MAQC Consortium, Shi, L., Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., Collins, P. J., de Longueville, F., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1239 · Cited by 2,126

Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

Sotiriou, C. P., Wirapati, P., Loi, S., Harris, A. L., Fox, S., Smeds, J., Nordgren, H., Farmer, P. J., Praz, V., Haibe‐Kains, B., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj052 · Cited by 2,050

Genes that mediate breast cancer metastasis to the brain

Bos, P. D., Zhang, X. H.-F., Nadal, C., Shu, W., Gomis, R. R., Nguyen, D. X., Minn, A. J., van de Vijver, M. J., Gerald, W. L., Foekens, J. A., et al. (2009) · Nature · doi:10.1038/nature08021 · Cited by 1,863

MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors

Schwarzenbacher, D., Klec, C., Pasculli, B., Cerk, S., Rinner, B., Karbiener, M., Ivan, C., Barbano, R., Ling, H. Y., Wulf-Goldenberg, A., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1104-5 · Cited by 91

RNA‐binding protein NONO promotes breast cancer proliferation by post‐transcriptional regulation of SKP2 and E2F8

Iino, K., Mitobe, Y., Ikeda, K., Takayama, K., Suzuki, T., Kawabata, H., Suzuki, Y., Horie‐Inoue, K., & Inoue, S. (2019) · Cancer Science · doi:10.1111/cas.14240 · Cited by 90

miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer

Parashar, D., Geethadevi, A., Aure, M. R. R., Mishra, J., George, J., Chen, C., Mishra, M. K., Tahiri, A., Zhao, W., Nair, B. J., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.085 · Cited by 88

LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer

Jin, X., Ge, L., Li, D., Shao, Z., Di, G. H., Xu, X., & Jiang, Y. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01210-9 · Cited by 91

The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma

Oca, R. M. D., Gurard‐Levin, Z. A., Berger, F., Rehman, H., Martel, E., Corpet, A., de Koning, L., Vassias, I., Wilson, L. O. W., Meseure, D., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.11.002 · Cited by 90

Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells

Chien, W., Ding, L., Sun, Q., Fernández, L. T., Tan, S. Z., Xiao, J.-F., Lim, S. L., Garg, M., Lee, K. L., Kitajima, S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2051 · Cited by 89

Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast Cancer

Broude, E. V., Győrffy, B., Chumanevich, A. A., Chen, M., McDermott, M. S. J., Shtutman, M. S., Catroppo, J. F., & Roninson, I. B. (2015) · Current Cancer Drug Targets · doi:10.2174/156800961508151001105814 · Cited by 90

Cytidine Deaminase Axis Modulated by miR-484 Differentially Regulates Cell Proliferation and Chemoresistance in Breast Cancer

Ye, F.-G., Song, C.-G., Cao, Z.-G., Chen, X., Chen, D.-N., Chen, L., Li, S., Qiao, F., Ling, H., Yao, L., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2341 · Cited by 89

Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti‐PD‐L1 antibody for treatment of triple‐negative breast cancer

Raninga, P. V., Lee, A. C. H., Sinha, D., Shih, Y., Mittal, D., Makhale, A., Bain, A. L., Nanayakkara, D. M., Tonissen, K. F., Kalimutho, M., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32410 · Cited by 89

TRIM29 Suppresses TWIST1 and Invasive Breast Cancer Behavior

Ai, L., Kim, W.-J., Alpay, M., Tang, M., Pardo, C. E., Hatakeyama, S., May, W. S., Kladde, M. P., Heldermon, C. D., Siegel, E. M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3579 · Cited by 91

HDAC8 cooperates with SMAD3/4 complex to suppress SIRT7 and promote cell survival and migration

Tang, X., Li, G., Su, F., Cai, Y., Shi, L., Meng, Y., Liu, Z., Sun, J., Wang, M., Qian, M., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa039 · Cited by 91

The Paradox of E-Cadherin: Role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism

Chu, K., Boley, K. M., Moraes, R., Barsky, S. H., & Robertson, F. M. (2013) · Oncotarget · doi:10.18632/oncotarget.872 · Cited by 88

α-catenin acts as a tumour suppressor in E-cadherin-negative basal-like breast cancer by inhibiting NF-κB signalling

Piao, H.-L., Yuan, Y., Wang, M., Sun, Y., Liang, H., & Ma, L. (2014) · Nature Cell Biology · doi:10.1038/ncb2909 · Cited by 91

HIC1 deletion promotes breast cancer progression by activating tumor cell/fibroblast crosstalk

Wang, Y., Weng, X., Wang, L., Hao, M., Li, Y., Hou, L., Liang, Y., Wu, T., Yao, M., Lin, G., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99974 · Cited by 89

EZH2 regulates PD-L1 expression via HIF-1α in non-small cell lung cancer cells

Zhao, Y., Wang, X., Wu, W., Long, H., Huang, J., Wang, Z., Li, T., Tang, S., Zhu, B., & Chen, D. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.07.039 · Cited by 91

Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer

Bacci, M., Lorito, N., Ippolito, L., Ramazzotti, M., Luti, S., Romagnoli, S., Parri, M., Bianchini, F., Cappellesso, F., Virga, F., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.010 · Cited by 88

Paclitaxel Induces Micronucleation and Activates Pro-Inflammatory cGAS–STING Signaling in Triple-Negative Breast Cancer

Hu, Y., Manasrah, B. K., McGregor, S. M., Lera, R. F., Norman, R. X., Tucker, J. B., Scribano, C. M., Yan, R. E., Humayun, M., Wisinski, K. B., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0195 · Cited by 89

Survival Genie, a web platform for survival analysis across pediatric and adult cancers

Dwivedi, B., Mumme, H., Satpathy, S., Bhasin, S. S., & Bhasin, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-06841-0 · Cited by 87

PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness

Wang, X., Jung, Y., Jun, S., Lee, S., Wang, W., Schneider, A., Oh, Y. S., Lin, S. H., Park, B.-J., Chen, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms10633 · Cited by 89

Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis

Martínez-Ordóñez, A., Seoane, S., Cabezas‐Sainz, P., Eiró, N., Sendón-Lago, J., Macia, M., García‐Caballero, T., González, L. O., Sanchez, L. E., Vizoso, F. J., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0036-8 · Cited by 86

G1P3 (IFI6), a mitochondrial localised antiapoptotic protein, promotes metastatic potential of breast cancer cells through mtROS

Cheriyath, V., Kaur, J. S., Davenport, A., Khalel, A. F., Chowdhury, N., & Gaddipati, L. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0137-3 · Cited by 86

Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes

Wang, J., Duan, Z., Nugent, Z. J., Zou, J. X., Borowsky, A. D., Zhang, Y., Tepper, C. G., Li, J. J., Fiehn, O., Xu, J., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.05.004 · Cited by 86

ΔNp63α Promotes Breast Cancer Cell Motility through the Selective Activation of Components of the Epithelial-to-Mesenchymal Transition Program

Dang, T. T., Esparza, M. A., Maine, E. A., Westcott, J. M., & Pearson, G. W. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3363 · Cited by 85

MOF Acetylates the Histone Demethylase LSD1 to Suppress Epithelial-to-Mesenchymal Transition

Luo, H., Shenoy, A. K., Li, X., Jin, Y., Jin, L., Cai, Q., Tang, M., Liu, Y., Chen, H., Reisman, D., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.050 · Cited by 85

Increased expression of TET3 predicts unfavorable prognosis in patients with ovarian cancer-a bioinformatics integrative analysis

Cao, T., Pan, W., Sun, X., & Shen, H. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0575-4 · Cited by 85

Immature natural killer cells promote progression of triple-negative breast cancer

Thacker, G., Henry, S., Nandi, A., Debnath, R., Singh, S., Nayak, A., Susnik, B., Boone, M., Zhang, Q. H., Kesmodel, S. B., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abl4414 · Cited by 88

SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker

Kolukula, V. K., Sahu, G., Wellstein, A., Rodriguez, O. C., Preet, A., Iacobazzi, V., D’Orazi, G., Albanese, C., Palmieri, F., & Avantaggiati, M. L. (2014) · Oncotarget · doi:10.18632/oncotarget.1831 · Cited by 86

SIRT3 Silencing Sensitizes Breast Cancer Cells to Cytotoxic Treatments Through an Increment in ROS Production

Torrens‐Mas, M., Pons, D. G., Sastre‐Serra, J., Oliver, J., & Roca, P. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25653 · Cited by 88

Roles for miRNAs in endocrine resistance in breast cancer

Muluhngwi, P., & Klinge, C. M. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0355 · Cited by 89

Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors

Pedersen, M. H., Hood, B. L., Beck, H. C., Conrads, T. P., Ditzel, H. J., & Leth‐Larsen, R. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1305531 · Cited by 88

Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy

Khouzam, R. A., Venkatesh, G. H., Zaarour, R. F., Chamseddine, A. N., Francis, A., Buart, S., Terry, S., & Chouaïb, S. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.003 · Cited by 84

Epigenetic Alterations in Triple-Negative Breast Cancer—The Critical Role of Extracellular Matrix

Zolota, V., Tzelepi, V., Piperigkou, Z., Kourea, H. P., Papakonstantinou, Ε., Argentou, M., & Karamanos, N. K. (2021) · Cancers · doi:10.3390/cancers13040713 · Cited by 85

Systematic Analysis of AU-Rich Element Expression in Cancer Reveals Common Functional Clusters Regulated by Key RNA-Binding Proteins

Hitti, E., Bakheet, T. M., Al‐Souhibani, N., Moghrabi, W. N., Al‐Yahya, S., Alghamdi, M. A., Al‐Saif, M., Shoukri, M. M., Lánczky, A., Grépin, R., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3110 · Cited by 83

MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib

Young, A. I. J., Law, A. M. K., Castillo, L. E., Chong, S., Cullen, H., Koehler, M., Herzog, S., Brummer, T., Lee, E. F., Fairlie, W. D., et al. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0781-6 · Cited by 81

Glucose-6-phosphate dehydrogenase and transketolase modulate breast cancer cell metabolic reprogramming and correlate with poor patient outcome

Benito, A., Polat, I. H., Noé, V., Ciudad, C. J., Marín, S., & Cascante, M. (2017) · Oncotarget · doi:10.18632/oncotarget.21601 · Cited by 88

Ubiquitin-conjugating enzyme E2T (UBE2T) and denticleless protein homolog (DTL) are linked to poor outcome in breast and lung cancers

Pérez‐Peña, J., Corrales‐Sánchez, V., Amir, E., Pandiella, A., & Ocaña, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-17836-7 · Cited by 83

Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program

Hirukawa, A., Smith, H. W., Zuo, D., Dufour, C. R., Savage, P., Bertos, N., Johnson, R. M., Bui, T., Bourque, G., Basik, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04864-8 · Cited by 85

E2F1 Drives Breast Cancer Metastasis by Regulating the Target Gene FGF13 and Altering Cell Migration

Hollern, D. P., Swiatnicki, M., Rennhack, J. P., Misek, S. A., Matson, B. C., McAuliff, A., Gallo, K. A., Caron, K. M., & Andrechek, E. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-47218-0 · Cited by 82

Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer

Ye, L., Lin, C., Wang, X., Li, Q., Li, Y., Wang, M., Zhao, Z., Wu, X., Shi, D., Xiao, Y., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910638 · Cited by 84

NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer

Zhou, L., Wang, D., Sheng, D., Xu, J., Chen, W., Qin, Y., Du, R., Yang, X., He, X., Xie, N., et al. (2020) · Theranostics · doi:10.7150/thno.38875 · Cited by 83

Estrogen Actions in Triple-Negative Breast Cancer

Treeck, O., Schüler‐Toprak, S., & Ortmann, O. (2020) · Cells · doi:10.3390/cells9112358 · Cited by 83

CXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity

Zhu, G., Yan, H. H., Pang, Y., Jiang, J., Achyut, B. R., Liang, X., Weiss, J. M., Wiltrout, R. H., Hollander, M. C., & Yang, H. H. (2015) · Oncotarget · doi:10.18632/oncotarget.6125 · Cited by 83

Altered purinergic receptor‐Ca2+ signaling associated with hypoxia‐induced epithelial‐mesenchymal transition in breast cancer cells

Azimi, I., Beilby, H., Davis, F. M., Marcial, D. L., Kenny, P. A., Thompson, E. W., Roberts‐Thomson, S. J., & Monteith, G. R. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.09.006 · Cited by 84

Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain

Gan, S., Macalinao, D. G., Shahoei, S. H., Tian, L. H., Jin, X., Basnet, H., Bibby, C., Muller, J., Atri, P., Seffar, E., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.08.015 · Cited by 96

RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma

Sakurai, T., Isogaya, K., Sakai, S., Morikawa, M., Morishita, Y., Ehata, S., Miyazono, K., & Koinuma, D. (2016) · Oncogene · doi:10.1038/onc.2016.35 · Cited by 82

Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma

Zhu, R., Liu, Y., Zhou, H., Li, L., Li, Y., Ding, F., Cao, X., & Liu, Z. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.025 · Cited by 81

Targeted matrisome analysis identifies thrombospondin-2 and tenascin-C in aligned collagen stroma from invasive breast carcinoma

Tomko, L. A., Hill, R. C., Barrett, A. S., Szulczewski, J. M., Conklin, M. W., Eliceiri, K. W., Keely, P. J., Hansen, K. C., & Ponik, S. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-31126-w · Cited by 84

The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer

Youngblood, V., Kim, L. C., Edwards, D. N., Hwang, Y., Santapuram, P. R., Stirdivant, S. M., Lu, P., Ye, F., Brantley‐Sieders, D. M., & Chen, J. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-0847 · Cited by 81

Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4

Ahmad, A., Ginnebaugh, K. R., Yin, S., Bollig-Fischer, A. B., Reddy, K. B., & Sarkar, F. H. (2015) · BMC Cancer · doi:10.1186/s12885-015-1561-x · Cited by 81

Inhibition of Established Micrometastases by Targeted Drug Delivery via Cell Surface–Associated GRP78

Miao, Y. R., Eckhardt, B. L., Cao, Y., Pasqualini, R., Argani, P., Arap, W., Ramsay, R. G., & Anderson, R. L. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2991 · Cited by 81

Establishing the Role of PPARβ/δ in Carcinogenesis

Peters, J. M., Gonzalez, F. J., & Müller, R. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.09.004 · Cited by 81

Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity

Giordano, C., Chemi, F., Panza, S., Barone, I., Bonofiglio, D., Lanzino, M., Cordella, A., Campana, A., Hashim, A., Rizza, P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6014 · Cited by 81

PPAR-delta promotes survival of breast cancer cells in harsh metabolic conditions

Wang, X., Wang, G., Shi, Y., Sun, L., Gorczynski, R. M., Li, Y., Xu, Z., & Spaner, D. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.41 · Cited by 82

The significance of cholesterol and its metabolite, 27-hydroxycholesterol in breast cancer

Nelson, E. R. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.021 · Cited by 84

Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis

Papageorgis, P., Ozturk, S., Lambert, A. W., Neophytou, C. M., Tzatsos, A., Wong, C. K., Thiagalingam, S., & Constantinou, A. I. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0607-y · Cited by 80

TP53 mutation‐correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53‐mutated breast cancers

Győrffy, B., Bottai, G., Lehmann‐Che, J., Kéri, G., Őrfi, L., Iwamoto, T., Desmedt, C., Bianchini, G., Turner, N. C., de Thé, H., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2013.12.018 · Cited by 80

MMP1 expression is activated by Slug and enhances multi-drug resistance (MDR) in breast cancer

Shen, C., Kuo, Y.-L., Chen, C., Chen, M., & Cheng, Y.-M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174487 · Cited by 80

Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers

Baldassarre, T., Truesdell, P. F., & Craig, A. W. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0900-z · Cited by 80

Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry

Capulli, M., Hristova, D., Valbret, Z., Carys, K., Arjan, R., Maurizi, A., Masedu, F., Cappariello, A., Rucci, N., & Teti, A. M. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0501-y · Cited by 84

Obesity-Associated Myeloid-Derived Suppressor Cells Promote Apoptosis of Tumor-Infiltrating CD8 T Cells and Immunotherapy Resistance in Breast Cancer

Gibson, J. T., Orlandella, R. M., Turbitt, W. J., Behring, M. P., Manne, U., Sorge, R. E., & Norian, L. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.590794 · Cited by 81

YAP and β-Catenin Cooperate to Drive Oncogenesis in Basal Breast Cancer

Quinn, H. M., Vogel, R., Popp, O., Mertins, P., Lan, L., Messerschmidt, C., Landshammer, A., Lisek, K., Château‐Joubert, S., Marangoni, E., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2801 · Cited by 83

Survival analysis in breast cancer using proteomic data from four independent datasets

Osz, Á., Lánczky, A., & Győrffy, B. (2020) · Scientific Reports · doi:10.1038/s41598-021-96340-5 · Cited by 69

Lipocalin 2: a potential therapeutic target for breast cancer metastasis

Hu, C., Yang, K., Li, M., Huang, W., Zhang, F., & Wang, H. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s181223 · Cited by 80

In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion

Thangavelu, P. U., Krenács, T., Dray, E. V., & Duijf, P. H. G. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0290-6 · Cited by 80

Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers

Vinet, M., Suresh, S., Maire, V., Monchecourt, C., Némati, F., Lesage, L., Pierre, F., Ye, M., Lescure, A., Brisson, A., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2114 · Cited by 79

KIF2C exerts an oncogenic role in nonsmall cell lung cancer and is negatively regulated by miR‐325‐3p

Gan, H., Lin, L., Hu, N., Yang, Y., Gao, Y. J., Yu, P., Chen, K., & Sun, B. (2019) · Cell Biochemistry and Function · doi:10.1002/cbf.3420 · Cited by 80

Aconitase 2 inhibits the proliferation of MCF-7 cells promoting mitochondrial oxidative metabolism and ROS/FoxO1-mediated autophagic response

Ciccarone, F., Leo, L. D., Lazzarino, G., Maulucci, G., Giacinto, F. D., Tavazzi, B., & Ciriolo, M. R. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0641-0 · Cited by 82

TFEB is a master regulator of tumor-associated macrophages in breast cancer

Li, Y., Hodge, J., Liu, Q., Wang, J., Wang, Y., Evans, T. D., Altomare, D., Yao, Y., Murphy, E. A., Razani, B., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000543 · Cited by 84

MicroRNA-101 Suppresses Tumor Cell Proliferation by Acting as an Endogenous Proteasome Inhibitor via Targeting the Proteasome Assembly Factor POMP

Zhang, X., Schulz‐Heddergott, R., Edmunds, S. J., Krüger, E., Markert, E. K., Gaedcke, J., Cormet‐Boyaka, E., Ghadimi, M. B., Beißbarth, T., Levine, A. J., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.05.036 · Cited by 78

ERα Binding by Transcription Factors NFIB and YBX1 Enables FGFR2 Signaling to Modulate Estrogen Responsiveness in Breast Cancer

Campbell, T. M., Castro, M. A. A., de Oliveira, K. G., Ponder, B. A. J., & Meyer, K. B. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1153 · Cited by 78

Berberine down-regulates IL-8 expression through inhibition of the EGFR/MEK/ERK pathway in triple-negative breast cancer cells

Kim, S., You, D., Jeong, Y., Yu, J., Kim, S. W., Nam, S. J., & Lee, J. E. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.08.004 · Cited by 78

TRIM21 mediates ubiquitination of Snail and modulates epithelial to mesenchymal transition in breast cancer cells

Jin, Y., Zhang, Y., Li, B., Zhang, J., Dong, Z., Hu, X., & Wan, Y. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.11.269 · Cited by 77

Down-Regulation of NDUFB9 Promotes Breast Cancer Cell Proliferation, Metastasis by Mediating Mitochondrial Metabolism

Li, L., Sun, H., Liu, X.-X., Gao, S., Jiang, H., Hu, X., & Jin, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144441 · Cited by 78

TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer

Elbaz, M., Ahirwar, D. K., Xiaoli, Z., Zhou, X., Lustberg, M. B., Nasser, M. W., Shilo, K., & Ganju, R. K. (2016) · Oncotarget · doi:10.18632/oncotarget.9663 · Cited by 78

The Mitochondrial Citrate Carrier (SLC25A1) Sustains Redox Homeostasis and Mitochondrial Metabolism Supporting Radioresistance of Cancer Cells With Tolerance to Cycling Severe Hypoxia

Hlouschek, J., Hansel, C., Jendrossek, V., & Matschke, J. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00170 · Cited by 82

E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter

Chu, J., Zhu, Y., Liu, Y., Sun, L., Lv, X., Wu, Y., Hu, P., Su, F., Gong, C., Song, E., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5128 · Cited by 77

Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse of Triple Negative Breast Cancer

Foulds, G. A., Vadakekolathu, J. N., Abdel-Fatah, T. M. A., Nagarajan, D., Reeder, S., Johnson, C., Hood, S. P., Moseley, P. M., Chan, S. Y. T., Pockley, A. G., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02028 · Cited by 77

ITGA2 promotes expression of ACLY and CCND1 in enhancing breast cancer stemness and metastasis

Adorno-Cruz, V., Hoffmann, A. D., Liu, X., Dashzeveg, N. K., Taftaf, R., Wray, B. D., Keri, R. A., & Liu, H. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.01.015 · Cited by 78

Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarization

Sheng, D., Ma, W., Zhang, R., Zhou, L., Deng, Q., Tu, J., Chen, W., Zhang, F., Gao, N., Dong, M., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003793 · Cited by 77

Definition of PKC-α, CDK6, and MET as Therapeutic Targets in Triple-Negative Breast Cancer

Hsu, Y.-H., Yao, J., Chan, L.-C., Wu, T.-J., Hsu, J. L., Fang, Y., Wei, Y., Wu, Y., Huang, W.-C., Liu, C., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0584 · Cited by 77

Functional and prognostic significance of the genomic amplification of frizzled 6 ( FZD6 ) in breast cancer

Corda, G., Sala, G., Lattanzio, R., Iezzi, M., Sallese, M., Fragassi, G., Lamolinara, A., Mirza, H., Barcaroli, D., Ermler, S., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4841 · Cited by 82

Role of RPL39 in Metaplastic Breast Cancer

Dave, B., Gonzalez, D. D., Zhi-Bin, L., Li, X., Wong, H. H., Granados-Principal, S. M., Ezzedine, N. E., Sieglaff, D. H., Ensor, J., Miller, K. D., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw292 · Cited by 81

Glutamic Pyruvate Transaminase GPT2 Promotes Tumorigenesis of Breast Cancer Cells by Activating Sonic Hedgehog Signaling

Cao, Y., Lin, S., Wang, Y., Chin, Y. E., Kang, L., & Mi, J. (2017) · Theranostics · doi:10.7150/thno.18992 · Cited by 76

The glutathione peroxidase 8 (GPX8)/IL-6/STAT3 axis is essential in maintaining an aggressive breast cancer phenotype

Khatib, A., Solaimuthu, B., Yosef, M. B., Rmaileh, A. A., Tanna, M., Oren, G., Frisch, M. S., Axelrod, J. H., Lichtenstein, M., & Shaul, Y. D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010275117 · Cited by 80

Pan-cancer analysis identifies BIRC5 as a prognostic biomarker

Beding, A. F., Larsson, P., Helou, K., Einbeigi, Z., & Parris, T. Z. (2022) · BMC Cancer · doi:10.1186/s12885-022-09371-0 · Cited by 81

Machine learning assisted analysis of breast cancer gene expression profiles reveals novel potential prognostic biomarkers for triple-negative breast cancer

Thalor, A., Joon, H. K., Singh, G., Roy, S., & Gupta, D. K. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.03.019 · Cited by 80

The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features

Aloia, A., Petrova, E., Tomiuk, S., Bissels, U., Déas, O., Saini, M., Zickgraf, F. M., Wagner, S., Spaich, S., Sütterlin, M., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0652-6 · Cited by 75

Metastasis regulation by PPARD expression in cancer cells

Zuo, X., Xu, W., Xu, M., Tian, R., Moussalli, M. J., Mao, F., Zheng, X., Wang, J., Morris, J. S., Gagea, M., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.91419 · Cited by 78

ATXN3 promotes breast cancer metastasis by deubiquitinating KLF4

Zou, H., Chen, H., Zhou, Z., Wan, Y., & Liu, Z. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.09.012 · Cited by 76

FKBP4 connects mTORC2 and PI3K to activate the PDK1/Akt-dependent cell proliferation signaling in breast cancer

Mangé, A., Coyaud, É., Desmetz, C., Laurent, E. M. N., Béganton, B., Coopman, P. J., Raught, B., & Solassol, J. (2019) · Theranostics · doi:10.7150/thno.35561 · Cited by 77

Histone Methyltransferase hSETD1A Is a Novel Regulator of Metastasis in Breast Cancer

Salz, T., Deng, C., Pampo, C., Siemann, D. W., Qiu, Y., Brown, K. D., & Huang, S. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0389 · Cited by 76

Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer

Srihari, S., Singla, J., Wong, L., & Ragan, M. A. (2015) · Biology Direct · doi:10.1186/s13062-015-0086-1 · Cited by 73

Prognostic values of distinct CBX family members in breast cancer

Liang, Y., Lin, H., Chen, C., & Zeng, D. (2017) · Oncotarget · doi:10.18632/oncotarget.21325 · Cited by 78

Intrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1

Lung, D. K., Reese, R., & Alarid, E. T. (2020) · Hormones and Cancer · doi:10.1007/s12672-020-00388-0 · Cited by 77

OTUD7B Deubiquitinates LSD1 to Govern Its Binding Partner Specificity, Homeostasis, and Breast Cancer Metastasis

Gong, Z., Li, A., Ding, J., Li, Q., Zhang, L., Li, Y., Meng, Z., Chen, F., Huang, J., Zhou, D., et al. (2021) · Advanced Science · doi:10.1002/advs.202004504 · Cited by 74

Clinical significance of CYLD downregulation in breast cancer

Hayashi, M., Jono, H., Shinriki, S., Nakamura, T., Guo, J., Sueta, A., Tomiguchi, M., Fujiwara, S., Yamamoto‐Ibusuki, M., Murakami, K.-I., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2824-3 · Cited by 75

Effective Targeting of Estrogen Receptor–Negative Breast Cancers with the Protein Kinase D Inhibitor CRT0066101

Borgés, S., Perez, E. A., Thompson, E. A., Radisky, D. C., Geiger, X. J., & Störz, P. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0945 · Cited by 76

TMEM2 Is a SOX4-Regulated Gene That Mediates Metastatic Migration and Invasion in Breast Cancer

Lee, H., Goodarzi, H., Tavazoie, S. F., & Alarcón, C. R. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2322 · Cited by 75

The WASF3–NCKAP1–CYFIP1 Complex Is Essential for Breast Cancer Metastasis

Teng, Y., Qin, H., Bahassan, A., Bendzunas, N. G., Kennedy, E. J., & Cowell, J. K. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0562 · Cited by 77

TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development

Czerwińska, P., Shah, P. K., Tomczak, K. J., Klimczak, M., Mazurek, S., Sozańska, B., Biecek, P., Korski, K., Filas, V., Mackiewicz, A. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13273 · Cited by 73

P1-07-18: Expanding an Online Tool for Genome-Wide Validation of Survival-Associated Biomarkers in Breast and Ovarian Cancer Using Microarray Data of 3,862 Patients.

Győrffy, B., Lánczky, A., & Szállási, Z. (2011) · Cancer Research · doi:10.1158/0008-5472.sabcs11-p1-07-18 · Cited by 70

Online biomarker validation of survival-associated biomarkers in breast and ovarian cancer using microarray data of 3,862 patients.

Győrffy, B., Lánczky, A., & Szállási, Z. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.15_suppl.10571

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

Sotiriou, C. P., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A. A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 2,024

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival

van Laar, R. K. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.12.003 · Cited by 12

bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer

Jézéquel, P., Campone, M., Gouraud, W., Guérin‐Charbonnel, C., Leux, C., Ricolleau, G., & Campion, L. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1457-7 · Cited by 410